Relationship between CD44high/CD133high/CD117high cancer stem cells phenotype and Cetuximab and Paclitaxel treatment response in head and neck cancer cell lines Article

Silva Galbiatti-Dias, Ana Livia, Mendonca Fernandes, Glaucia Maria, Urbanin Castanhole-Nunes, Marcia Maria et al. (2018). Relationship between CD44high/CD133high/CD117high cancer stem cells phenotype and Cetuximab and Paclitaxel treatment response in head and neck cancer cell lines . 8(8), 1633-1641.

cited authors

  • Silva Galbiatti-Dias, Ana Livia; Mendonca Fernandes, Glaucia Maria; Urbanin Castanhole-Nunes, Marcia Maria; Hidalgo, Luiza Fernandes; Viesi Nascimento Filho, Carlos Henrique; Kawasaki-Oyama, Rosa Sayoko; Muniz Ferreira, Leticia Antunes; Biselli-Chicote, Patricia Mattos; Pavarino, Erika Cristina; Goloni-Bertollo, Eny Maria

sustainable development goals

authors

publication date

  • January 1, 2018

keywords

  • CARCINOMA
  • CD44
  • CHEMOTHERAPY RESISTANCE
  • CONTRIBUTES
  • Cancer stem cells
  • EGFR
  • EPITHELIAL-MESENCHYMAL-TRANSITION
  • GROWTH-FACTOR RECEPTOR
  • HETEROGENEITY
  • IDENTIFICATION
  • LUNG-CANCER
  • Life Sciences & Biomedicine
  • Oncology
  • Science & Technology
  • cell line
  • chemotherapy
  • expression
  • gene
  • head and neck neoplasias

publisher

  • E-CENTURY PUBLISHING CORP

start page

  • 1633

end page

  • 1641

volume

  • 8

issue

  • 8